Podcast - Biopharmaceutical Manufacturing in India: The Challenges - - BioPharm International

ADVERTISEMENT

Podcast - Biopharmaceutical Manufacturing in India: The Challenges




Ajit Mahadevan
Leader of Biotech initiatives for the India Life Sciences Practices at Ernst & Young

Add this Podcast feed to your media player



Faced with economic pressures and budget constraints, biopharmaceutical companies are increasingly looking at outsourcing as a cost-effective alternative. In this interview, Ajit Mahadevan, Leader of Biotech initiatives for the India Life Sciences Practices at Ernst & Young, discusses current trends and challenges of outsourcing biomanufacturing-related activities to India.

Click here to go to the main podcast page >>>


Related Links:
India Today by Eric Langer
Outsourcing Insights by Jim Miller
Perspectives on Outsourcing
blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

GPhA Issues Statement on Generic Drug Costs
November 20, 2014
Amgen Opens Single-Use Manufacturing Plant in Singapore
November 20, 2014
Manufacturing Issues Crucial to Combating Ebola
November 20, 2014
FDA Requests Comments on Generic Drug Submission Criteria
November 20, 2014
USP Joins Chinese Pharmacopoeia Commission for Annual Science Meeting
November 20, 2014
Author Guidelines

Click here